TARGETED DELIVERY OF NEW ANTISENSE MOLECULES FOR REGENERATION ENHANCEMENT AFTER SPINAL CORD INJURY

Project Information

SCIREGENASENSE

Grant agreement ID: 300485

Project closed

Start date 1 January 2013

End date 31 December 2014

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 157 748,40

EU contribution € 157 748,40

Coordinated by

INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
Portugal